152
Views
55
CrossRef citations to date
0
Altmetric
Review

Vaccination approaches against Trypanosoma cruzi infection

, &
Pages 921-935 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Fernando J Sánchez-Valdéz, Cecilia Pérez Brandán, Arturo Ferreira & Miguel Ángel Basombrío. (2015) Gene-deleted live-attenuated Trypanosoma cruzi parasites as vaccines to protect against Chagas disease. Expert Review of Vaccines 14:5, pages 681-697.
Read now
Eric Dumonteil, Maria Elena Bottazzi, Bin Zhan, Michael J Heffernan, Kathryn Jones, Jesus G Valenzuela, Shaden Kamhawi, Jaime Ortega, Samuel Ponce de Leon Rosales, Bruce Y Lee, Kristina M Bacon, Bernhard Fleischer, BT Slingsby, Miguel Betancourt Cravioto, Roberto Tapia-Conyer & Peter J Hotez. (2012) Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospects. Expert Review of Vaccines 11:9, pages 1043-1055.
Read now
Israel Quijano-Hernandez & Eric Dumonteil. (2011) Advances and challenges towards a vaccine against Chagas disease. Human Vaccines 7:11, pages 1184-1191.
Read now

Articles from other publishers (52)

Abel Ramos-Vega, Elizabeth Monreal-Escalante, Sergio Rosales-Mendoza, Bernardo Bañuelos-Hernández, Eric Dumonteil & Carlos Angulo. (2023) Trypanosoma cruzi Tc24 Antigen Expressed and Orally Delivered by Schizochytrium sp. Microalga is Immunogenic in Mice. Molecular Biotechnology.
Crossref
Luciana L. Soprano, Maximiliano R. Ferrero, Thomas Jacobs, Alicia S. Couto & Vilma G. Duschak. (2023) Hallmarks of the relationship between host and Trypanosoma cruzi sulfated glycoconjugates along the course of Chagas disease. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Cazorla S. I.Alonso-Padilla Julio, W. De Souza & Padilla A. M.. (2022) Editorial: Understanding anti-trypanosomatid immune responses: The key to developing protective strategies against them. Frontiers in Immunology 13.
Crossref
Luciana L. Soprano, Maximiliano R. Ferrero, Malena Landoni, Gabriela A. García, Mónica I. Esteva, Alicia S. Couto & Vilma G. Duschak. (2022) Cruzipain Sulfotopes-Specific Antibodies Generate Cardiac Tissue Abnormalities and Favor Trypanosoma cruzi Infection in the BALB/c Mice Model of Experimental Chagas Disease. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Kamal Rawal, Robin Sinha, Bilal Ahmed Abbasi, Amit Chaudhary, Swarsat Kaushik Nath, Priya Kumari, P. Preeti, Devansh Saraf, Shachee Singh, Kartik Mishra, Pranjay Gupta, Astha Mishra, Trapti Sharma, Srijanee Gupta, Prashant Singh, Shriya Sood, Preeti Subramani, Aman Kumar Dubey, Ulrich Strych, Peter J. Hotez & Maria Elena Bottazzi. (2021) Identification of vaccine targets in pathogens and design of a vaccine using computational approaches. Scientific Reports 11:1.
Crossref
Eric Dumonteil & Claudia Herrera. (2021) The Case for the Development of a Chagas Disease Vaccine: Why? How? When?. Tropical Medicine and Infectious Disease 6:1, pages 16.
Crossref
Lucas D. Caeiro, Yamil E. Masip, Mariana Rizzi, Matías E. Rodríguez, Celeste Pueblas Castro, Daniel O. Sánchez, M. Lorena Coria, Juliana Cassataro & Valeria Tekiel. (2020) The Trypanosoma cruzi TcTASV-C protein subfamily administrated with U-Omp19 promotes a protective response against a lethal challenge in mice. Vaccine 38:48, pages 7645-7653.
Crossref
María Belén Antonoglou, Andrés Sánchez Alberti, Daniela María Redolfi, Augusto Ernesto Bivona, María Julieta Fernández Lynch, Sofía Noli Truant, María Belén Sarratea, Laura Valeria Iannantuono López, Emilio Luis Malchiodi & Marisa Mariel Fernández. (2020) Heterologous Chimeric Construct Comprising a Modified Bacterial Superantigen and a Cruzipain Domain Confers Protection Against Trypanosoma cruzi Infection. Frontiers in Immunology 11.
Crossref
Maharana, Sudhakar, Jawalagatti, Saravanan, Blake & Tewari. (2020) Evaluation of the Immunoprotective Potential of Recombinant Paraflagellar Rod Proteins of Trypanosoma evansi in Mice. Vaccines 8:1, pages 84.
Crossref
Paul B. ThompsonPaul B. Thompson. 2020. Food and Agricultural Biotechnology in Ethical Perspective. Food and Agricultural Biotechnology in Ethical Perspective 137 165 .
Gabriel Cabrera & Iván Marcipar. (2019) Vaccines and the regulatory arm of the immune system. An overview from the Trypanosoma cruzi infection model. Vaccine 37:28, pages 3628-3637.
Crossref
Wael Hegazy-Hassan, José Antonio Zepeda-Escobar, Laucel Ochoa-García, J.M. Eloy Contreras-Ortíz, Esvieta Tenorio-Borroto, Alberto Barbabosa-Pliego, José Esteban Aparicio-Burgos, Rigoberto Oros-Pantoja, Bruno Rivas-Santiago, Héctor Díaz-Albiter, Nisha Jain Garg & Juan Carlos Vázquez-Chagoyán. (2019) TcVac1 vaccine delivery by intradermal electroporation enhances vaccine induced immune protection against Trypanosoma cruzi infection in mice. Vaccine 37:2, pages 248-257.
Crossref
Laura C. Laurella, Natacha Cerny, Augusto E. Bivona, Andrés Sánchez Alberti, Gustavo Giberti, Emilio L. Malchiodi, Virginia S. Martino, Cesar A. Catalan, María Rosario Alonso, Silvia I. Cazorla & Valeria P. Sülsen. (2017) Assessment of sesquiterpene lactones isolated from Mikania plants species for their potential efficacy against Trypanosoma cruzi and Leishmania sp.. PLOS Neglected Tropical Diseases 11:9, pages e0005929.
Crossref
Estefanía Prochetto, Carolina Roldán, Iván A. Bontempi, Daiana Bertona, Luz Peverengo, Miguel H. Vicco, Luz M. Rodeles, Ana R. Pérez, Iván S. Marcipar & Gabriel Cabrera. (2017) Trans-sialidase-based vaccine candidate protects against Trypanosoma cruzi infection, not only inducing an effector immune response but also affecting cells with regulatory/suppressor phenotype . Oncotarget 8:35, pages 58003-58020.
Crossref
Marina N. Matos, Silvia I. Cazorla, Kai Schulze, Thomas Ebensen, Carlos A. Guzmán & Emilio L. Malchiodi. (2017) Immunization with Tc52 or its amino terminal domain adjuvanted with c-di-AMP induces Th17+Th1 specific immune responses and confers protection against Trypanosoma cruzi. PLOS Neglected Tropical Diseases 11:2, pages e0005300.
Crossref
A.M. Padilla, C.P. Brandan & M.A. Basombrío. 2017. American Trypanosomiasis Chagas Disease. American Trypanosomiasis Chagas Disease 773 796 .
M. C. Sharma. (2016) STRUCTURAL FEATURE STUDY OF FUROXAN DERIVATIVES AS POTENT ANTI-TRYPANOSOMATID AGENTS: QSAR APPROACH. INDIAN DRUGS 53:09, pages 12-21.
Crossref
Elitza S. Theel & Bobbi S. Pritt. 2016. Diagnostic Microbiology of the Immunocompromised Host. Diagnostic Microbiology of the Immunocompromised Host 411 466 .
Elitza S. Theel & Bobbi S. Pritt. (2016) Parasites. Microbiology Spectrum 4:4.
Crossref
Gabriel Antonio Nogueira NascentesCésar Gómez HernándezRosiley Aparecida de Souza RabeloRaquel Fernandes CoelhoFabiana Rossetto de MoraisTatiane MarquesLara Rocha BatistaWendell Sérgio Ferreira MeiraCarlo José Freire de OliveiraEliane Lages SilvaLuis Eduardo Ramírez. (2016) The Driving of Immune Response by Th1 Adjuvants in Immunization of Mice with Trypanosoma cruzi marinkellei Elicits a Controversial Infection Control . Vector-Borne and Zoonotic Diseases 16:5, pages 317-325.
Crossref
Beatriz Basso, Vanina Marini, Diego Gauna & Maria Frias. (2016) Vaccination of dogs with Trypanosoma rangeli induces antibodies against Trypanosoma cruzi in a rural area of Córdoba, Argentina. Memórias do Instituto Oswaldo Cruz 111:4, pages 271-274.
Crossref
Maximiliano R. Ferrero, Anja M. Heins, Luciana L. Soprano, Diana M. Acosta, Mónica I. Esteva, Thomas Jacobs & Vilma G. Duschak. (2015) Involvement of sulfates from cruzipain, a major antigen of Trypanosoma cruzi, in the interaction with immunomodulatory molecule Siglec-E. Medical Microbiology and Immunology 205:1, pages 21-35.
Crossref
S. I. Cazorla, M. N. Matos, N. Cerny, C. Ramirez, A. S. Alberti, A. E. Bivona, C. Morales, C. A. Guzman & E. L. Malchiodi. (2014) Oral Multicomponent DNA Vaccine Delivered by Attenuated Salmonella Elicited Immunoprotection Against American Trypanosomiasis. Journal of Infectious Diseases 211:5, pages 698-707.
Crossref
Isabela Resende Pereira, Glaucia Vilar-Pereira, Virgínia Marques, Andrea Alice da Silva, Bráulia Caetano, Otacilio Cruz Moreira, Alexandre Vieira Machado, Oscar Bruna-Romero, Maurício Martins Rodrigues, Ricardo Tostes Gazzinelli & Joseli Lannes-Vieira. (2015) A Human Type 5 Adenovirus-Based Trypanosoma cruzi Therapeutic Vaccine Re-programs Immune Response and Reverses Chronic Cardiomyopathy. PLOS Pathogens 11:1, pages e1004594.
Crossref
Olivia Rodríguez-Morales, Víctor Monteón-Padilla, Silvia C. Carrillo-Sánchez, Martha Rios-Castro, Mariana Martínez-Cruz, Alejandro Carabarin-Lima & Minerva Arce-Fonseca. (2015) Experimental Vaccines against Chagas Disease: A Journey through History. Journal of Immunology Research 2015, pages 1-8.
Crossref
Marina N. Matos, Silvia I. Cazorla, Augusto E. Bivona, Celina Morales, Carlos A. Guzmán & Emilio L. Malchiodi. (2014) Tc52 Amino-Terminal-Domain DNA Carried by Attenuated Salmonella enterica Serovar Typhimurium Induces Protection against a Trypanosoma cruzi Lethal Challenge. Infection and Immunity 82:10, pages 4265-4275.
Crossref
Maximiliano R. Ferrero, Luciana L. Soprano, Diana M. Acosta, Gabriela A. García, Mónica I. Esteva, Alicia S. Couto & Vilma G. Duschak. (2014) Effects of chlorate on the sulfation process of Trypanosoma cruzi glycoconjugates. Implication of parasite sulfates in cellular invasion. Acta Tropica 137, pages 161-173.
Crossref
B. Basso & V. Marini. (2014) Experimental Chagas disease. Innate immune response in Balb/c mice previously vaccinated with Trypanosoma rangeli. I. The macrophage shows immunological memory: Reality or fiction?. Immunobiology 219:4, pages 275-284.
Crossref
Adriano Fernando Araújo, Gabriel de Oliveira, Juliana Fraga Vasconcelos, Jonatan Ersching, Mariana Ribeiro Dominguez, José Ronnie Vasconcelos, Alexandre Vieira Machado, Ricardo Tostes Gazzinelli, Oscar Bruna-Romero, Milena Botelho Soares & Mauricio Martins Rodrigues. (2014) Genetic Vaccination against Experimental Infection with Myotropic Parasite Strains of Trypanosoma cruzi . Mediators of Inflammation 2014, pages 1-13.
Crossref
Fernando dos Santos Virgilio, Camila Pontes, Mariana Ribeiro Dominguez, Jonatan Ersching, Mauricio Martins Rodrigues & José Ronnie Vasconcelos. (2014) CD8 + T Cell-Mediated Immunity during Trypanosoma cruzi Infection: A Path for Vaccine Development? . Mediators of Inflammation 2014, pages 1-12.
Crossref
SAM ALSFORD, JOHN M. KELLY, NICOLA BAKER & DAVID HORN. (2013) Genetic dissection of drug resistance in trypanosomes. Parasitology 140:12, pages 1478-1491.
Crossref
Jessica C. Kling & Heinrich Körner. (2013) Different regulatory mechanisms in protozoan parasitic infections. International Journal for Parasitology 43:6, pages 417-425.
Crossref
Raquel Tayar Nogueira, Alanderson Rocha Nogueira, Mirian Claudia Souza Pereira, Maurício Martins Rodrigues, Patrícia Cristina da Costa Neves, Ricardo Galler & Myrna Cristina Bonaldo. (2013) Recombinant Yellow Fever Viruses Elicit CD8+ T Cell Responses and Protective Immunity against Trypanosoma cruzi. PLoS ONE 8:3, pages e59347.
Crossref
Christian Emerson Rosas-Jorquera, Luiz Roberto Sardinha, Fernando Delgado Pretel, André Luis Bombeiro, Maria Regina D'Império Lima & José Maria Alvarez. (2013) Challenge of Chronically Infected Mice with Homologous Trypanosoma cruzi Parasites Enhances the Immune Response but Does Not Modify Cardiopathy: Implications for the Design of a Therapeutic Vaccine. Clinical and Vaccine Immunology 20:2, pages 248-254.
Crossref
Nicole Klein, Ivy Hurwitz & Ravi Durvasula. 2013. Dynamic Models of Infectious Diseases. Dynamic Models of Infectious Diseases 139 167 .
Alicia S. Couto, Luciana L. Soprano, Malena Landoni, Marilyne Pourcelot, Diana M. Acosta, Laurent Bultel, Juliana Parente, Maximiliano R. Ferrero, Maximilien Barbier, Christophe Dussouy, Mónica I. Esteva, José Kovensky & Vilma G. Duschak. (2012) An anionic synthetic sugar containing 6-SO 3 -NAcGlc mimics the sulfated cruzipain epitope that plays a central role in immune recognition . The FEBS Journal 279:19, pages 3665-3679.
Crossref
Adriana Egui, M. Carmen Thomas, María Morell, Concepción Marañón, Bartolomé Carrilero, Manuel Segovia, Concepción J. Puerta, María Jesús Pinazo, Fernando Rosas, Joaquim Gascón & Manuel Carlos López. (2012) Trypanosoma cruzi paraflagellar rod proteins 2 and 3 contain immunodominant CD8+ T-cell epitopes that are recognized by cytotoxic T cells from Chagas disease patients. Molecular Immunology 52:3-4, pages 289-298.
Crossref
Luciana Lima, Paola A. Ortiz, Flávia Maia da Silva, João Marcelo P. Alves, Myrna G. Serrano, Alane P. Cortez, Silvia C. Alfieri, Gregory A. Buck & Marta M. G. Teixeira. (2012) Repertoire, Genealogy and Genomic Organization of Cruzipain and Homologous Genes in Trypanosoma cruzi, T. cruzi-Like and Other Trypanosome Species. PLoS ONE 7:6, pages e38385.
Crossref
Mauricio M. Rodrigues, Ana Carolina Oliveira & Maria Bellio. (2012) The Immune Response to Trypanosoma cruzi : Role of Toll-Like Receptors and Perspectives for Vaccine Development . Journal of Parasitology Research 2012, pages 1-12.
Crossref
Ernesto S. Nakayasu, Tiago J. P. Sobreira, Rafael Torres, Luciane Ganiko, Paulo S. L. Oliveira, Alexandre F. Marques & Igor C. Almeida. (2011) Improved Proteomic Approach for the Discovery of Potential Vaccine Targets in Trypanosoma cruzi . Journal of Proteome Research 11:1, pages 237-246.
Crossref
Andrea Pellegrini, Natalia Guiñazu, Laura Giordanengo, Roxana Carolina Cano & Susana Gea. (2011) The role of Toll-like receptors and adaptive immunity in the development of protective or pathological immune response triggered by the Trypanosoma cruzi protozoan . Future Microbiology 6:12, pages 1521-1533.
Crossref
Peter Hotez. (2011) Enlarging the “Audacious Goal”: Elimination of the world's high prevalence neglected tropical diseases. Vaccine 29, pages D104-D110.
Crossref
Gisela C. Muscia, Silvia I. Cazorla, Fernanda M. Frank, Gabriela L. Borosky, Graciela Y. Buldain, Silvia E. Asís & Emilio L. Malchiodi. (2011) Synthesis, trypanocidal activity and molecular modeling studies of 2-alkylaminomethylquinoline derivatives. European Journal of Medicinal Chemistry 46:9, pages 3696-3703.
Crossref
Valeria P. Sülsen, Fernanda M. Frank, Silvia I. Cazorla, Patricia Barrera, Blanca Freixa, Roser Vila, Miguel A. Sosa, Emilio L. Malchiodi, Liliana V. Muschietti & Virginia S. Martino. (2011) Psilostachyin C: a natural compound with trypanocidal activity. International Journal of Antimicrobial Agents 37:6, pages 536-543.
Crossref
Vanina Marini, Edgardo Moretti, Daniela Bermejo & Beatriz Basso. (2011) Vaccination with Trypanosoma rangeli modulates the profiles of immunoglobulins and IL-6 at local and systemic levels in the early phase of Trypanosoma cruzi experimental infection. Memórias do Instituto Oswaldo Cruz 106:1, pages 32-37.
Crossref
Eva Rawlings Parker & Aisha Sethi. (2011) Chagas Disease: Coming to a Place Near You. Dermatologic Clinics 29:1, pages 53-62.
Crossref
Santuza M. Teixeira, Najib M. El-Sayed & Patrícia R. Araújo. 2011. Chagas Disease, Part A. Chagas Disease, Part A 209 230 .
Mohammed Sajid, Stephanie A. Robertson, Linda S. Brinen & James H. McKerrow. 2011. Cysteine Proteases of Pathogenic Organisms. Cysteine Proteases of Pathogenic Organisms 100 115 .
Guilherme Malafaia & Aline Sueli de Lima Rodrigues. (2010) Centenário do descobrimento da doença de Chagas: desafios e perspectivas. Revista da Sociedade Brasileira de Medicina Tropical 43:5, pages 483-485.
Crossref
François-Xavier Lescure, Guillaume Le Loup, Hector Freilij, Michel Develoux, Luc Paris, Laurent Brutus & Gilles Pialoux. (2010) Chagas disease: changes in knowledge and management. The Lancet Infectious Diseases 10:8, pages 556-570.
Crossref
Angel Marcelo Padilla, Cecilia Perez Brandan & Miguel Angel Basombrío. 2010. American Trypanosomiasis. American Trypanosomiasis 827 848 .
Filipe A. Haolla, Carla Claser, Bruna C.G. de Alencar, Fanny Tzelepis, José Ronnie de Vasconcelos, Gabriel de Oliveira, Jaline C. Silvério, Alexandre V. Machado, Joseli Lannes-Vieira, Oscar Bruna-Romero, Ricardo T. Gazzinelli, Ricardo Ribeiro dos Santos, Milena B.P. Soares & Mauricio M. Rodrigues. (2009) Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection. Vaccine 27:41, pages 5644-5653.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.